Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
Rang in aandelen #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Aandeelprijs
$0.05137558
Laatst gesynchroniseerd: 2026-08-13
Marktkapitalisatie
$1.88M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-11.66%
Land
CA
Handel Restart Life Sciences Corp. (HEAL)

Categorie

Dividendrendementgeschiedenis voor Restart Life Sciences Corp. (HEAL)
Het dividendrendement (TTM) van Restart Life Sciences Corp. (aandelsymbool: HEAL) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Restart Life Sciences Corp. (HEAL) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten